At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 30 enrolled
Drug / intervention
Adapalene 0.1% and Benzoyl Peroxide 2.5% geldrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Assessment of Subjects' Efficacy and Experiences Using Adapalene BPO Gel in the Treatment of Acne Vulgaris
In Brief
A Phase 4 clinical trial evaluating Adapalene 0.1% and Benzoyl Peroxide 2.5% gel for Acne Vulgaris. Completed, enrolled 30 participants across 1 site.
Detailed Summary
The purpose of this study is to assess subjects' experiences using Adapalene BPO gel to treat mild to moderate acne vulgaris using efficacy measurements, quality of life instruments, and video diaries.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Vulgaris
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedSep 2010
Enrollment StartOct 2010
Primary CompletionJan 2011
TodayJul 2026
First PostedSep 27, 2010
Enrollment StartOct 1, 2010
Primary CompletionJan 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 15.8 years ago
Interventions
Adapalene 0.1% and Benzoyl Peroxide 2.5% geldrug
Apply adapalene BPO gel once daily in the evening for 12 weeks